Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Seraph Group
AddedFeb 13, 2024
UpdatedJul 16, 2026
Seraph Group

Seraph Group

Operating

Seraph Group: An early-stage venture firm investing in technology startups, offering $100K-$2M in capital.

Location
Lisle, IL, US
Founded
2005
Firm
Compare
Portfolio
Employees
Website

Seraph Group is an early-stage venture firm specializing in technology startups, providing seed and early-stage capital ranging from $100K to $2M. The firm focuses on a diversified portfolio of technology companies, supporting entrepreneurs through various investment rounds including Seed, Series A, Series B, and beyond.

Notable portfolio companies include Eko Health, Kyte, Lucira Health, and Syntiant. Seraph Group's investment philosophy centers on bringing together successful individuals passionate about tech investments. The firm offers unique value-add services, leveraging the expertise and networks of its partners to support the growth and success of its portfolio companies.

Seraph Group - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments43
Current Portfolio Count26
Total Portfolio Exits3

Top Investment Stages

Seed12 (32.4%)
Series A10 (27.0%)
Series B8 (21.6%)
Angel4 (10.8%)
Pre-Seed3 (8.1%)

Stage Mix

Seed 32%Series A 27%Series B 22%Angel 11%Pre-Seed 8%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Flywheel logo

Flywheel

Autio logo

Autio

GridRival logo

GridRival

Natilus logo

Natilus

Venus Aerospace logo

Venus Aerospace

Kyte logo

Kyte

Motivo logo

Motivo

Digbi Health logo

Digbi Health

Lucira Health logo

Lucira Health

LiteraSeed logo

LiteraSeed

Zeto logo

Zeto

Eko Health logo

Eko Health

Molecula logo

Molecula

Syntiant logo

Syntiant

Button Wallet logo

Button Wallet

Supermedium logo

Supermedium

Jido Maps logo

Jido Maps

PolyPort logo

PolyPort

INF Care logo

INF Care

Ava logo

Ava

LifeSignals logo

LifeSignals

Second Genome logo

Second Genome

NuMedii logo

NuMedii

Tribogenics logo

Tribogenics

Sanguine logo

Sanguine

Seraph Group - Classification

Also Known As
  • Seraph Group, Inc.
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 7300Business Services
Show 2 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541000Professional, Scientific, and Technical Services